Towards modulating the gut microbiota to enhance the efficacy of immune-checkpoint inhibitors

Rebecca Simpson; Erin R. Shanahan; Richard A Scolyer; Georgina V. Long

doi:10.1038/s41571-023-00803-9

Related publications

Article2025

Advances and mechanisms of gut microbiota modulation in enhancing immune checkpoint inhibitor efficacy

Liqiao Chen, Baoyi Li, Menghang Zu, Rui L Reis, Subhas C. Kundu, Bo Xiao

Article2020

Elucidating the gut microbiota composition and the bioactivity of immunostimulatory commensals for the optimization of immune checkpoint inhibitors

Romain Daillère, Bertrand Routy, Anne‐Gaëlle Goubet, Alexandria P. Cogdill, Gladys Ferrere, Carolina Alves-Costa Silva, Aurélie Fluckiger, Pierre Ly, Yacine Haddad, Eugénie Pizzato, Cassandra Thélémaque, Marine Fidelle, Marine Mazzenga, María Paula Roberti, Cléa Melenotte, Peng Liu, Safae Terrisse, Oliver Kepp, Guido Guido Kroemer, Laurence Zitvogel, Lisa Derosa

Article2020

Efficacy of immune checkpoint inhibitors for in-transit melanoma

Georgina V. Long, Grant A. McArthur, Shahneen Sandhu, Robyn P.M. Saw, Euan Walpole, Alexander M. Menzies, B. Mark Smithers, David Gyorki, Emilia Nan Tie, Julia Lai‐Kwon, Michael Rtshiladze, Lumine Na, J Bozzi, Tavis Read, Victoria Atkinson, George Au‐Yeung

Article2019

Efficacy of immune checkpoint inhibitors (ICIs) for in-transit melanoma.

Emilia Nan Tie, Julia Elizabeth Lai-Kwon, Lumine Na, Michael Rtshiladze, J Bozzi, Tavis Read, Victoria Atkinson, George Au‐Yeung, Georgina V. Long, Grant A. McArthur, Shahneen Sandhu, Robyn P.M. Saw, Euan Walpole, Alexander M. Menzies, B. Mark Smithers, David Gyorki

Article2021

Immune checkpoint inhibitors

Guido Guido Kroemer, Laurence Zitvogel